Cullen/Frost Bankers, Inc. Abcam PLC Transaction History

Cullen/Frost Bankers, Inc.

  • $7.23 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023
BUY
$12.98 - $17.1 $3,335 - $4,394
257 New
257 $3,000

Others Institutions Holding ABCM

# of Institutions
4
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Abcam plc

ABCM Quotes by TradingView
  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email